Tue Oct 30, 2007 - Forbes Medi-Tech Inc. (TSX:FMI and NASDAQ:FMTI) announced that it has entered the final stages of compound selection for two of the most rapidly growing therapeutic indications, asthma and type 2 diabetes... Forbes Medi-Tech's Press Release -
Showing posts with label Forbes Medi-Tech. Show all posts
Showing posts with label Forbes Medi-Tech. Show all posts
Nov 6, 2007
Forbes Medi-Tech, Final Steps in Compound Selection for Asthma
Tue Oct 30, 2007 - Forbes Medi-Tech Inc. (TSX:FMI and NASDAQ:FMTI) announced that it has entered the final stages of compound selection for two of the most rapidly growing therapeutic indications, asthma and type 2 diabetes... Forbes Medi-Tech's Press Release -
Subscribe to:
Comments (Atom)
